Inger Nina Farstad

Inger Nina Farstad is a Professor in the Department of Pathology at the University of Oslo. Her work focuses on translational medical research with a strong emphasis on oncology, immunology, and gastrointestinal disorders. She has contributed to studies involving machine learning applications in healthcare, targeted therapies for melanoma, and the role of microbiota in systemic sclerosis. Her research spans clinical outcomes prediction, biomarker development, and surgical innovations for chronic conditions like Hirschsprung's disease and intestinal failure.

Farstad's research integrates molecular biology, computational methods, and clinical data to address challenges in cancer treatment, immune dysfunction, and gastrointestinal diseases. Collaborations with multidisciplinary teams have yielded insights into AXL receptor inhibition in melanoma, predictive models for colorectal cancer outcomes, and the use of faecal microbiota transplantation in autoimmune contexts.

Her publications highlight contributions to understanding disease mechanisms and improving diagnostic/prognostic tools. She is affiliated with Rikshospitalet (National Hospital) in Oslo, reflecting her translational research focus bridging laboratory and clinical settings.